Colitis in ocrelizumab-treated patients: The dilemma of causation versus association in immune-mediated iatrogenicity

Published 2023 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Colitis in ocrelizumab-treated patients: The dilemma of causation versus association in immune-mediated iatrogenicity
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 29, Issue 10, Pages 1201-1203
Publisher
SAGE Publications
Online
2023-09-15
DOI
10.1177/13524585231195853
References
View 8 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.